Redeye is positive about Paxman’s regulatory clearance in the EU and UK for its CIPN device. We view this as a significant milestone, transforming Paxman from a single-product company into a two-product company and reducing concentration risk. The company will soon initiate a pilot launch in the UK, with further updates about a broader launch expected during the remainder of 2026.
LÄS MER
